In addition, number of nevi and melanoma risk have been associated with variants in the CDKN2A gene [6], which plays a role in cell cycle regulation, while CDKN2A inactivation has been shown to be common in breast cancer [25]. Here, CDKN2A is linked to breast carcinoma.